Analysts expect UNITED THERAPEUTICS Corp to report revenue of 798.22 M for Q3 26, against a range of 745.80 M to 850.65 M. The most recent reported quarter, Q2 26, came in at 783.30 M, a 5.6% miss against the 830.05 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 748.90 M | 735.90 M | 794.40 M | 798.60 M | 799.50 M | 790.20 M | 781.50 M | 783.30 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 722.77 M | 841.80 M | 826.64 M | 888.22 M | 925.24 M | 819.81 M | 794.51 M | 871.06 M | 850.65 M | 836.95 M | 877.30 M | 831.22 M | 823.58 M | 894.66 M | 1.07 B | 999.96 M | ||||||||||
| Low Estimate | 634.54 M | 719.35 M | 715.93 M | 777.03 M | 780.42 M | 747.46 M | 699.02 M | 789.04 M | 745.80 M | 724.66 M | 773.50 M | 706.46 M | 750.35 M | 795.48 M | 1.00 B | 925.32 M | ||||||||||
| Consensus Estimate | 678.65 M | 780.58 M | 771.29 M | 832.62 M | 852.83 M | 783.63 M | 746.76 M | 830.05 M | 798.22 M | 780.81 M | 825.40 M | 768.84 M | 786.97 M | 845.07 M | 1.04 B | 962.64 M |
Analysts expect UNITED THERAPEUTICS Corp to report earnings per share of 6.15 for Q3 26, against a range of 5.62 to 6.68. The most recent reported quarter, Q2 26, came in at 7.27, a 12.2% beat against the 6.48 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 6.39 | 6.19 | 6.63 | 6.41 | 7.16 | 7.70 | 5.82 | 7.27 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 6.42 | 6.26 | 7.36 | 7.46 | 7.39 | 7.27 | 7.00 | 7.04 | 6.68 | 7.68 | 7.96 | 8.12 | 7.46 | 8.68 | 9.40 | 10.20 | ||||||||||
| Low Estimate | 6.00 | 5.74 | 6.62 | 6.38 | 6.27 | 6.27 | 6.40 | 5.92 | 5.62 | 6.68 | 7.10 | 7.20 | 6.92 | 8.00 | 8.46 | 9.00 | ||||||||||
| Consensus Estimate | 6.21 | 6.00 | 6.99 | 6.92 | 6.83 | 6.77 | 6.70 | 6.48 | 6.15 | 7.18 | 7.53 | 7.66 | 7.19 | 8.34 | 8.93 | 9.60 |
Pull Wall Street consensus for UNITED THERAPEUTICS Corp (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=UTHR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "UTHR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=UTHR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();